Chen, Xiaowei
No ORCID on file
· 14 papers in corpus
· active 2024
Study types
- other 10
- article 4
Condition tags
- endometriosis 14
Frequent coauthors
- Fan, Qingnan 14
- Jin, Linxi 14
- Jiang, Yuepeng 14
- Ke, Huanxiao 14
- Ma, Jing 14
- Tang, Hongying 14
- Zhao, Xiaoxuan 14
- Zhao, Yang 14
- Zhang, Yuanyuan 14
article
2024
Supplementary Material 1: Supplement table 1. Immune localization of EMs signature genes.
article
2024
Supplementary Material 1: Supplement table 1. Immune localization of EMs signature genes.
article
2024
Supplementary Material 2: Supplement table 2. Tests for normality distribution and homogeneity of variance.
article
2024
Supplementary Material 2: Supplement table 2. Tests for normality distribution and homogeneity of variance.
other
2024
Supplementary Material 3: Supplement figure 1. Correlation plot of eutopic disulfidptosis-related DEGs (A) and ectopic disulfidptosis-related DEGs (B) remaining after filtering out those with high correlation.
other
2024
Supplementary Material 3: Supplement figure 1. Correlation plot of eutopic disulfidptosis-related DEGs (A) and ectopic disulfidptosis-related DEGs (B) remaining after filtering out those with high correlation.
other
2024
Supplementary Material 4: Supplement figure 2. ROC curve for BLR, LASSO, SVM-RFE, and XGBoost algorithms in relation to eutopic (A) and ectopic (B) tissues.
other
2024
Supplementary Material 4: Supplement figure 2. ROC curve for BLR, LASSO, SVM-RFE, and XGBoost algorithms in relation to eutopic (A) and ectopic (B) tissues.
other
2024
Supplementary Material 5: Supplement figure 3. The ROC curves of signature genes in eutopic and ectopic endometrial tissues, respectively. (A-G) The ROC of eutopic signature genes. (H-L) The ROC of ectopic signature genes.
other
2024
Supplementary Material 5: Supplement figure 3. The ROC curves of signature genes in eutopic and ectopic endometrial tissues, respectively. (A-G) The ROC of eutopic signature genes. (H-L) The ROC of ectopic signature genes.
other
2024
Supplementary Material 6: Supplement figure 4. Candidate compound screening. The association network of signature genes with medicine. Core nodes: signature genes. Peripheral nodes: medicine. The Approved drug node color is yellow-red, the …
other
2024
Supplementary Material 6: Supplement figure 4. Candidate compound screening. The association network of signature genes with medicine. Core nodes: signature genes. Peripheral nodes: medicine. The Approved drug node color is yellow-red, the …
other
2024
Abstract Background Endometriosis (EMs) is an enigmatic disease of yet-unknown pathogenesis. Disulfidptosis, a novel identified form of programmed cell death resulting from disulfide stress, stands a chance of treating diverse ailments. How…
other
2024
Abstract Background Endometriosis (EMs) is an enigmatic disease of yet-unknown pathogenesis. Disulfidptosis, a novel identified form of programmed cell death resulting from disulfide stress, stands a chance of treating diverse ailments. How…